Assessment of Drug–Drug Interaction Potential Between Atorvastatin and LCZ696, A Novel Angiotensin Receptor Neprilysin Inhibitor, in Healthy Chinese Male Subjects
Crossref DOI link: https://doi.org/10.1007/s13318-016-0349-y
Published Online: 2016-05-31
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ayalasomayajula, Surya
Pan, Wei
Han, Yi
Yang, Fan
Langenickel, Thomas
Pal, Parasar
Zhou, Wei
Yuan, Yaozong
Rajman, Iris
Sunkara, Gangadhar
Funding for this research was provided by:
Novartis Pharma AG, Basel, Switzerland
License valid from 2016-05-31